179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Saved in:
Bibliographic Details
Published in:J Thorac Oncol
Main Authors: Pierre, C., Goter, T., Agar, C., Luzi, S., Lena, H., Guen, Y. Le, Ricordel, C.
Format: Artigo
Language:Inglês
Published: International Association for the Study of Lung Cancer. Published by Elsevier Inc. Published by Elsevier Inc. 2021
Subjects:
Advanced Nsclc
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7997779/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1556-0864(21)02021-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items